等待开盘 02-04 09:30:00 美东时间
-0.550
-5.87%
EKSO BIONICS ( ($EKSO) ) has shared an update. On January 20, 2026, Ekso Bionic...
01-23 06:18
Ekso Bionics (EKSO) on Wednesday said it entered into securities purchase agreements on Jan. 20, 2026, with institutional and accredited investors for a private placement of 5,852 shares of Series B p...
01-21 22:06
Ekso Bionics Holdings announced on January 21, 2026, that it entered into securities purchase agreements with investors to sell 5,852 shares of Series B Preferred Stock and warrants for up to 355,960 common shares in a private placement. The Preferred Stock carries a stated value of $1,000 per share, convertible into 711,922 common shares at $8.22 each, with voting rights on an as-converted basis. Warrants are exercisable at $8.22 per share, expi...
01-21 13:30
Applied Digital is in advanced talks with an IG hyperscaler and plans to spin out its cloud compute segment.
01-09 22:03
Applied Digital will release its Q2 earnings report on Wednesday after the closing bell. Here is what to expect.
01-08 03:22
Applied Digital (NASDAQ:APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads,
2025-12-30 05:52
Applied Digital and EKSO announced a proposed business combination to form ChronoScale, an accelerated GPU platform tailored for next-generation AI workloads. The merger aims to leverage Applied Digital's cloud infrastructure expertise and EKSO's resources to deliver scalable, efficient compute solutions in a capacity-constrained market. ChronoScale will focus on AI-native and enterprise customers, offering rapid deployment and reliable performan...
2025-12-29 21:45
Ekso Bionics has partnered with MediTouch to become the exclusive distributor of the BalanceTutor rehabilitation system in the U.S. The BalanceTutor uses a 4D perturbation treadmill and sensors to help patients with balance impairments react to disturbances while walking safely. Ekso Bionics CEO Scott Davis expressed excitement about expanding their technology portfolio and enhancing patient care. Moshe Druker, of MediTouch, highlighted the colla...
2025-12-04 12:45
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises the price target from $4 to $6.
2025-11-18 23:42